ART-Treated Patients Exhibit an Adaptive Immune Response against the HFVAC Peptides, a Potential HIV-1 Therapeutic Vaccine (Provir/Latitude45 Study)

We proposed a new HIV-1 therapeutic vaccine based on conserved cytotoxic T lymphocyte (CTL) epitopes of archived HIV-1 DNA according to their affinity to the dominant HLA-A and -B alleles of the population investigated. Our proposal (Hla Fitted VAC, HFVAC) was composed of 15 peptides originating fro...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Viruses
Egile Nagusiak: Fleury, Hervé, Caldato, Sabrina, Recordon-Pinson, Patricia, Thebault, Patricia, Guidicelli, Gwenda-Line, Hessamfar, Mojgan, Morlat, Philippe, Bonnet, Fabrice, Visentin, Jonathan
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2020
Gaiak:
Brief Report
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7694376/
https://ncbi.nlm.nih.gov/pubmed/33167335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/v12111256
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak